Abstract
For the current issue of the Journal, we asked Dr Derryck H Smith to comment on and put into context the recent Cochrane review on the use of various atypical antipsychotic medications for adolescents with psychosis (1).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
